August 31, 2021 07:24 AM EDTUpdated 09:40 AM
Coronavirus

Covid-19 roundup: South Ko­re­an vac­cine to go up against As­traZeneca shot in small Phase III; CD­C's ACIP af­firms full ap­proval for Pfiz­er/BioN­Tech vac­cine

Josh Sullivan

SK Bio­science, a South Ko­re­an com­pa­ny, and Glax­o­SmithK­line will test their Covid-19 vac­cine can­di­date against As­traZeneca’s shot in about 4,000 peo­ple, the com­pa­nies said Tues­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

IGM Bio­sciences’ au­toim­mune piv­ot lasts three months af­ter in­ter­im da­ta dis­ap­point

Shore­line cuts staff as its part­ner­ship with Gilead­'s Kite is now in flux

Ver­sant un­veils Light Horse with $62M and a part­ner­ship with No­var­tis

Ex­clu­sive: First-of-its-kind in­fant DNA ed­it leads to ap­par­ent cure in dis­ease that set back field 25 years ago

Aio­los team re­unites with $411M for new biotech with obe­si­ty drugs from Chi­na

Af­ter lack­lus­ter 2024, bio­phar­ma in­dus­try prays stalled M&A will fi­nal­ly move in­to gear

A service from the Financial Times